Hepatitis C Seroprevalence and Associated Risk Factors, Anyang, China
Fangfang Liu1, Ke Chen1, Zhonghu He, Tao Ning, Yaqi Pan, Hong Cai , and Yang Ke
Author affiliations: Ministry of Education Key Laboratory, Beijing, People’s Republic of China (F. Liu, K. Chen, T. Ning, Y. Pan, H. Cai, Y. Ke); Peking University School of Oncology, Beijing (F. Liu, K. Chen, T. Ning, Y. Pan, H. Cai, Y. Ke); Beijing Cancer Hospital and Institute, Beijing (F. Liu, K. Chen, T. Ning, Y. Pan, H. Cai, Y. Ke); Peking University School of Public Health, Beijing (Z. He)
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.